CClinicalTrials.gg
CompletedNCT05679700Updated Jul 8, 2024

The Effect of Rigid Taping in Chronic Stroke Patients With Knee Hyperextension

An interventional study of Rigid Taping in Chronic Stroke, sponsored by Hacettepe University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-07-08.

Sponsored by Hacettepe University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

In this study, it is aimed to examine the effect of rigid taping on hyperextension control in stroke patients with knee hyperextension in the stance phase of gait.

Hypothesis Ho: Rigid taping has no effect on the control of knee hyperextension in stroke patients.

H1: Rigid taping has an effect on the control of knee hyperextension in stroke patients.

02

Conditions studied

  • Chronic Stroke

Browse trials for

Keywords

  • Gait Analysis
  • Stroke
  • Knee Hyperextension
  • Rigid Taping
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 30 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Hacettepe University is the lead sponsor of 983 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Having had a stroke at least 6 months ago
  • Ambulation with or without a walking aid (walker, cane or tripod)
  • To be between 0-3 points according to the Modified Rankin Scoring
  • Presence of spasticity in any of the lower extremity muscles with a value of at least 1 according to the Modified Ashworth Scale
  • Getting a score of 24 or higher on the Mini Mental Test
  • Presence of hyperextension in the stance phase of gait

Exclusion criteria

Exclusion Criteria:

  • Having more than one stroke history
  • Being diagnosed with dementia
  • Having a previous diagnosis of orthopedic, psychiatric or other neurological disease
  • Having a situation that prevents communication
  • History of surgery or joint contracture involving the lower extremities and gait
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Chronic stroke patients with knee hyperextension

    Other: Rigid Taping

Interventions

  • OtherRigid Taping

    Rigid taping was applied to stroke patients with knee hyperextension.

06

What researchers measure

Primary outcomes

  1. Vicon Motion Capture System

    A total of 16 reflective signs will be placed on certain anatomical points of the participants. Gait analysis will be performed at a distance of 5 meters from the participants. The three-dimensional positions of the reflective marks will be recorded with the 8-camera Vicon motion capture system.

    Time frame: Baseline

  2. Blade Software System

    Data obtained from Vicon motion capture system will be processed with Blade software. With the blade software, kinematic data will be obtained in the computer environment.

    Time frame: Baseline

07

Study locations

1 site
  • Hacettepe University
    Altındağ, Ankara 06230, Turkey
08

References and documents

Publications

  • Cooper A, Alghamdi GA, Alghamdi MA, Altowaijri A, Richardson S. The relationship of lower limb muscle strength and knee joint hyperextension during the stance phase of gait in hemiparetic stroke patients. Physiother Res Int. 2012 Sep;17(3):150-6. doi: 10.1002/pri.528. Epub 2011 Dec 7. PubMed 22147298 ↗
  • Geerars M, Minnaar-van der Feen N, Huisstede BMA. Treatment of knee hyperextension in post-stroke gait. A systematic review. Gait Posture. 2022 Jan;91:137-148. doi: 10.1016/j.gaitpost.2021.08.016. Epub 2021 Aug 24. PubMed 34695721 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05679700
Lead sponsor
Hacettepe University
Responsible party
Suleyman Korkusuz (Principal Investigator, Hacettepe University) — Principal investigator
First posted
Jan 11, 2023
Start date
Dec 30, 2022
Primary completion
Oct 11, 2023
Completion
Nov 15, 2023
Last update
Jul 8, 2024

Study contacts

Kadriye Armutlu, Prof. Dr.
study chair · Hacettepe University
Süleyman Korkusuz, MSc
principal investigator · Hacettepe University
Mehmet Akif Topçuoğlu, Prof. Dr.
study chair · Hacettepe University
Serdar Arıtan, Asst.Prof
study chair · Hacettepe University
Nihat Özgören, MSc
study chair · Hacettepe University
Ali Naim Ceren, Msc
study chair · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion